OPTIMAL TESTOSTERONE CONCENTRATION FOR THE TREATMENT OF PROSTATIC-CANCER

被引:31
作者
TRACHTENBERG, J [1 ]
机构
[1] UNIV TORONTO,DEPT SURG,DIV UROL,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
D O I
10.1016/S0022-5347(17)49273-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:888 / 890
页数:3
相关论文
共 9 条
[1]  
Brendler H, 1973, Urology, V2, P99, DOI 10.1016/0090-4295(73)90238-0
[2]  
BURT FB, 1957, STEROID RESPONSE HOR, V10, P825
[3]  
GELLER J, 1984, SEMINARS UROLOGY, V1, P291
[4]  
LABRIE F, 1982, J CLIN INVEST MED, V5, P267
[5]   BILATERAL ADRENALECTOMY FOR PALLIATIVE TREATMENT OF PROSTATIC CANCER [J].
MAHONEY, EM ;
HARRISON, JH .
JOURNAL OF UROLOGY, 1972, 108 (06) :936-&
[6]   CATECHOLESTROGENS AND INDUCTION OF SEXUAL-BEHAVIOR IN THE OVARIECTOMIZED RAT [J].
NAISH, SJ ;
BALL, P .
NEUROENDOCRINOLOGY, 1981, 32 (04) :225-228
[7]  
SIMPSONHERREN L, 1970, CANCER CHEMOTH REP 1, V54, P143
[8]   CORRELATION OF PROSTATIC NUCLEAR ANDROGEN RECEPTOR CONTENT WITH DURATION OF RESPONSE AND SURVIVAL FOLLOWING HORMONAL-THERAPY IN ADVANCED PROSTATIC-CANCER [J].
TRACHTENBERG, J ;
WALSH, PC .
JOURNAL OF UROLOGY, 1982, 127 (03) :466-471
[9]  
Walsh P C, 1975, Urol Clin North Am, V2, P125